SmokeFreeBrain brings together experts in toxicology, pulmonary medicine, neuroscience, and behavioral therapy, as well as health economics and health informatics. They are examining the effectiveness of anti-smoking strategies aimed at high-risk groups in high-middle-income countries, such as unemployed adults, people with chronic pulmonary disease and asthma patients – as well as the general population in lower-middle-income countries.